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Pertussis toxin activates T lymphocytes by a mechanism that is independent of its ADP-ribosylation activity. The toxin 
stimulates increases in diacylglycerol and intracellular calcium apparently by interacting with a cell surface receptor. Con- 
sistent with the production of these second messengers we have found that pertussis toxin activates protein kinase C 
in the Jurkat cell line. The toxin was also found to activate a tyrosine protein kinase in these cells in a manner similar 
to that observed with phytohemagluttinin. These results provide evidence that the mechanism of activation of T cells 
by pertussis toxin involves stimulating the activity of protein kinase C and a tyrosine protein kinase. 
Tyrosine phosphorylation; Pertussis toxin; (T cell) 
1. INTRODUCTION 
Pertussis toxin, produced by Bordetella per- 
tussis, is mitogenic for both human and murine T 
cells [1,2]. Although pertussis toxin exerts its ef- 
fects in many systems through its ability to ADP- 
ribosylate certain G transducer proteins, its mito- 
genie effect on T cells is independent of this en- 
zymatic activity. This mitogenic effect of the toxin 
resides in its non-catalytic, membrane-binding sub- 
unit referred to as the B-oligomer [2]. It has been 
suggested that the B-oligomer can bring about the 
cross-linking of specific receptors in a manner 
similar to that of other agents that activate T cells 
via cell surface receptors [2]. A common property 
of agents that activate T cells via receptor-mediated 
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mechanisms is the ability to stimulate increases in 
intracellular calcium and diacylglycerol levels [3]. 
Studies with the Jurkat cell line have shown that 
pertussis toxin can also cause rapid increases in 
these two intracellular messengers [4], lending sup- 
port to the idea that the toxin acts by stimulating a 
specific receptor. Pertussis toxin has also been 
shown to increase intracellular calcium in normal 
human peripheral T cells [5]. One result of in- 
creases in the level of these two second messengers 
could be the activation of protein kinase C, an en- 
zyme critical for the activation of T lymphocytes 
131. 
The stimulation of tyrosine protein kinase has 
also been implicated as playing a role in the activa- 
tion of T lymphocytes. Stimulation of the antigen 
receptor and the thy1 receptor on a T cell 
hybridoma causes activation of a tyrosine protein 
kinase [6,7]. If this increase in tyrosine phosphory- 
lation is involved in the signal transduction path- 
way leading to the activation of T cells, then one 
would expect to see increases in tyrosine phospho- 
rylation with other agents that activate T cells. We 
have tested these ideas by examining the ability of 
pertussis toxin to activate both protein kinase C 
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and a tyrosine protein kinase in the human T cell 
line Jurkat . 
2. EXPERIMENTAL 
The Jurkat cell line was maintained in Iscove’s medium sup- 
plemented with 10% fetal calf serum. Antibodies specific for 
phosphotyrosine were prepared as in [8,9]. Antibodies specific 
for ~~56”’ were produced using a decapeptide with the 
carboxyl-terminal sequence of ~~56’~~. The antipeptide anti- 
bodies were prepared in rabbits as described [lo]. Immunoblots 
were performed as in [g-10] using ?-protein A to detect the 
immune complexes. Intracellular calcium measurements with 
the indicator Fura-Z/AM were accomplished as described by 
Grynkiewicz et al. [ll] using a final cell density of 5 x lo6 
cells/ml. For the dose-response curves the relative increases in 
calcium were measured at the plateau of the fluorescence scans 
at each concentration of pertussis toxin. The increase in phos- 
photyrosine was determined in cells treated for 10 min with per- 
tussis toxin and were quantitated by counting the region of the 
immunoblot containing the 42 kDa band in a gamma counter. 
3. RESULTS 
If the increases in diacylglycerol and calcium 
observed with pertussis toxin are significant with 
regard to its mechanism of T cell activation, then 
stimulation of T cells with pertussis toxin should 
result in activation of protein kinase C. An unam- 
biguous approach for monitoring the intracellular 
activation of protein kinase C is to examine the 
level of in vivo phosphorylation of substrates for 
this enzyme. The phosphorylation of the T cell 
tyrosine protein kinase ~~56’~ by protein kinase C 
is easily detected on SDS gels since this phosphory- 
lation results in a shift in the apparent molecular 
mass of pp561ck to forms that run at 64 and 70 kDa 
[lo, 121. The appearance of higher molecular mass 
forms of pp561Ck can thus be used as a means of 
monitoring the activation of protein kinase C in T 
cells. Using this approach we examined the ability 
of pertussis toxin to increase the activity of protein 
kinase C in Jurkat cells. 
Fig.1 shows the results of an immunoblot with 
antibodies to pp56iCk. In control cells most of 
pp56iCk migrates with a molecular mass of 56 kDa. 
Some pp561ck is present in a form of 64 kDa and 
this appears to be due to some basal phosphoryla- 
tion by protein kinase C (Casnellie, J., unpublish- 
ed). Treatment of Jurkat cells with pertussis toxin 
causes most of pp561Ck to be converted to the higher 
molecular mass forms. The effect of pertussis toxin 
was nearly comparable to that obtained when the 
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Fig. 1. Formation of higher molecular mass forms of pp561ck as 
a result of in vivo phosphorylation by protein kinase C. Jurkat 
cells were incubated for 15 min with no addition (CON), 60 nM 
pertussis toxin (PT) or 50 nM PMA (PMA). After dissolving in 
SDS, samples were subjected to immunoblotting with anti- 
bodies to ~~56’~~. The arrow indicates the species of ~~56”~ of 
56 kDa, the arrowheads denoting positions of higher molecular 
mass forms. 
cells are treated with the active phorbol ester PMA, 
a potent direct activator of protein kinase C. These 
results indicate a strong activation of protein 
kinase C in response to pertussis toxin. 
Fig.2 shows that this treatment with pertussis 
toxin also stimulated dramatic increases in phos- 
CON PT PHA 
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Fig.2. Autoradiogram comparing pertussis toxin-stimulated 
tyrosine phosphorylation to that seen with PHA. Jurkat cells 
were incubated for 10 min after addition of nothing (CON), 
60 nM pertussis toxin (PT) or 10 /g/ml purified PHA (PHA). 
The cells were dissolved in SDS and immunoblotted using anti- 
bodies to phosphotyrosine. The filled arrowheads indicate 
bands that increase over those seen in control cells and the open 
arrowheads indicate new bands that are induced by pertussis 
toxin or PHA. 
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photyrosine in several proteins. There is increased 
phosphorylation over basal levels in three proteins 
of 60, 112 and 118 kDa and de novo tyrosine phos- 
phorylation of four other proteins with apparent 
molecular masses of 42, 80, 85 and 120 kDa. Fig.2 
also shows the effect of PHA on the level of 
tyrosine phosphorylation in Jurkat cells. PHA is a 
strong activator of Jurkat cells and appears to 
function by stimulating the antigen receptor com- 
plex on these cells [13]. The substrate profile and 
relative magnitudes of PHA-induced tyrosine 
phosphorylation closely mimic that seen with per- 
tussis toxin. The tyrosine phosphorylation induced 
by pertussis toxin was readily detected at 1 min 
(not shown). As shown in fig.3 phosphorylation 
reached its maximal evel within 5 min and remain- 
ed elevated for the 3 h incubation period. 
The function of tyrosine phosphorylation in T 
cells is unknown but its rapid occurrence upon 
stimulation suggests a role in activation. Increases 
in calcium appear to be essential for the production 
of interleukin 2 by Jurkat cells [13]. A comparison 
of the pertussis toxin dose-response curves for both 
tyrosine phosphorylation and the rise in intra- 
cellular calcium is shown in fig.4. The dose- 
response curves for the two responses have a 
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Fig.3. Autoradiogram of a phosphotyrosine antibody immuno- 
blot showing the time course of pertussis toxin-dependent 
tyrosine phosphorylation. Cells were incubated for the indicated 
time (in min) with 60 nM pertussis toxin. These times include 
the 3 min required for pelleting the cells. The cells were then 
dissolved in SDS and immunoblotted with antibodies specific 
for phosphotyrosine. 
LOG [Perlbssis Toxin] 
Fig.4. Dose responses for pertussis toxin-dependent tyrosine 
phosphorylation and increases in intracellular calcium. Relative 
increases in intracellular calcium and tyrosine phosphorylation 
were measured under identical conditions, as described in sec- 
tion 2; (m---W) calcium signal; (El---nil) increase in tyrosine 
phosphorylation. 
similar shape and occur at similar concentrations 
with half-maximal responses occurring at 3 x lo-* 
and 0.8 x lo-* M for stimulation of tyrosine phos- 
phorylation and calcium increases, respectively. 
Thus, increases in tyrosine phosphorylation will 
occur over most of the range of concentrations of 
pertussis toxin that stimulate increases in calcium. 
4. DISCUSSION 
Our results demonstrate that pertussis toxin 
stimulates the activity of protein kinase C and a 
tyrosine protein kinase in T lymphocytes. Thus, ac- 
tivation of these protein kinases may contribute to 
the mitogenic response of T cells to pertussus toxin. 
The activation of protein kinase C is consistent 
with earlier studies showing that this toxin can 
stimulate the phosphatidylinositol pathway in T 
cells. The non-catalytic membrane-binding moiety 
of pertussis toxin, the B-oligomer, has been shown 
to be responsible for the toxin’s ability to increase 
cell calcium and stimulate phosphatidylinositol 
hydrolysis in T cells. Although we have not 
specifically addressed the role of the B-oligomer in 
the induction of tyrosine phosphorylation by per- 
tussis toxin, the similarity of the time course and 
dose-response curve of this response to the increase 
in calcium strongly suggest hat this phosphoryla- 
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tion is also due to the interaction of the toxin with 
a specific membrane receptor rather than the ADP- 
ribosylation of a G-protein. The rapid induction of 
tyrosine phosphorylation also argues that this is a 
receptor-mediated reaction. In cells where the 
response to pertussis toxin is due to ADP- 
ribosylation the effects reach a maximum only 
after several hours of incubation [14,15]. 
The effect of pertussis toxin on tyrosine phos- 
phorylation was identical to that observed with 
PHA, suggesting that both agents stimulate the ac- 
tivity of the same tyrosine protein kinase. This 
result provides support for the idea that pertussis 
toxin activates T cells by virtue of its ability to 
function like a plant lectin. Our demonstration that 
pertussis toxin stimulates tyrosine phosphorylation 
at concentrations similar to that needed to 
stimulate increases in cell calcium indicate that this 
tyrosine phosphorylation could be relevant to T 
cell activation. 
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